Skip to content

Drug interactions

Golimumab + Meningococcal group b vaccine

Severity: Moderate

Golimumab and Meningococcal group b vaccine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Golimumab, a TNF blocker, can blunt the antibody response to non-live vaccines such as meningococcal group B vaccine. Patients may therefore be incompletely protected after vaccination, although the vaccine is not unsafe.

What this interaction means in plain words

Golimumab and Meningococcal group b vaccine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

TNF inhibition causes immunosuppression that may reduce vaccine-induced immune responses.

What to do

Where possible, give the vaccine before starting golimumab or at a time when the dose schedule allows. Do not delay vaccination in at-risk patients, and consider checking for protection or following local guidance on boosters.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Golimumab and Meningococcal group b vaccine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Golimumab with Meningococcal group b vaccine?

MediHelp rates the interaction as moderate. Golimumab and Meningococcal group b vaccine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Golimumab, a TNF blocker, can blunt the antibody response to non-live vaccines such as meningococcal group B vaccine. Patients may therefore be incompletely protected after vaccination, although the vaccine is not unsafe.

How serious is the interaction between Golimumab and Meningococcal group b vaccine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Where possible, give the vaccine before starting golimumab or at a time when the dose schedule allows. Do not delay vaccination in at-risk patients, and consider checking for protection or following local guidance on boosters.

What other medicines interact with Golimumab?

MediHelp also lists interactions of Golimumab with, for example, Bcg vaccine live, Etanercept, Influenza virus vaccine quadrivalent intranasal. The full list is on the Golimumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in